Mechanisms of Sensory Hair Cell Death and Survival
Project Number1R01DC007613-01
Contact PI/Project LeaderCUNNINGHAM, LISA L
Awardee OrganizationMEDICAL UNIVERSITY OF SOUTH CAROLINA
Description
Abstract Text
DESCRIPTION (provided by applicant): Sensory hair cells are hypersensitive to death induced by noise, aging, and some therapeutic drugs. Two major classes of ototoxic drugs are the aminoglycoside antibiotics and the antineoplastic agent cisplatin. We plan to take advantage of a unique in vitro preparation of the adult mouse utricle that allows us to examine the rrechanisms underlying ototoxic hair cell death and survival at the molecular level. Understanding these cellular mechanisms will be critical for the design of therapies aimed at preventing or reversing hearing loss. The induction of heat shock proteins (HSPs) in response to cellular stress is a ubiquitous and highlyconserved response that can significantly inhibit apoptosis in some systems. Induction of HSPs occurs in hair cells in response to a variety of stimuli. However, there are no studies on the effects of HSPs on ototoxic drug-induced hair cell death. More importantly, there are no data available regarding the cellular interactions between HSPs and apoptotic proteins in hair cells in response to any stimulus. Our preliminary data demonstrate that in vitro heat shock treatment inhibits hair cell death in response to both neomycin and cisplatin exposure. The experiments in this proposal are designed to test the hypothesis that the protective effect of heat shock against ototoxic drug-induced hair cell death is the result of HSP-mediated inhibition of specific apoptotic signaling pathways. Four groups of experiments are proposed: 1). To examine the similarities and differences between the molecular mechanisms mediating cisplatin- vs. aminoglycoside-induced hair cell death. 2). To determine whether heat shock treatment is sufficient to induce a shift in the dose-response relationship between ototcxic drug concentration and hair cell survival. 3). To determine whether induction of HSP-70 is necessary and sufficient for the protective effect of heat shock against ototoxic hair cell apoptosis. 4). To investigate the interactions between HSPs and apoptotic proteins in hair cells exposed to ototoxic drugs.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
aminoglycoside antibioticsantineoplasticsapoptosisbiological signal transductioncell deathcisplatincytotoxicitydosagedrug adverse effectear hair cellheat shock proteinslaboratory mousemolecular pathologypathologic processprotein structure function
National Institute on Deafness and Other Communication Disorders
CFDA Code
173
DUNS Number
183710748
UEI
NHV3GTWSALA7
Project Start Date
15-July-2005
Project End Date
30-June-2010
Budget Start Date
15-July-2005
Budget End Date
30-June-2006
Project Funding Information for 2005
Total Funding
$365,000
Direct Costs
$250,000
Indirect Costs
$115,000
Year
Funding IC
FY Total Cost by IC
2005
National Institute on Deafness and Other Communication Disorders
$365,000
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R01DC007613-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R01DC007613-01
Patents
No Patents information available for 1R01DC007613-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R01DC007613-01
Clinical Studies
No Clinical Studies information available for 1R01DC007613-01
News and More
Related News Releases
No news release information available for 1R01DC007613-01
History
No Historical information available for 1R01DC007613-01
Similar Projects
No Similar Projects information available for 1R01DC007613-01